Your browser doesn't support javascript.
loading
Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis.
Nechanitzky, Robert; Nechanitzky, Duygu; Ramachandran, Parameswaran; Duncan, Gordon S; Zheng, Chunxing; Göbl, Christoph; Gill, Kyle T; Haight, Jillian; Wakeham, Andrew C; Snow, Bryan E; Bradaschia-Correa, Vivian; Ganguly, Milan; Lu, Zhibin; Saunders, Mary E; Flavell, Richard A; Mak, Tak W.
Afiliação
  • Nechanitzky R; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Nechanitzky D; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Ramachandran P; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Duncan GS; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Zheng C; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Göbl C; Department of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
  • Gill KT; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Haight J; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Wakeham AC; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Snow BE; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Bradaschia-Correa V; Histology Core, The Centre for Phenogenomics, Toronto, ON, Canada.
  • Ganguly M; Histology Core, The Centre for Phenogenomics, Toronto, ON, Canada.
  • Lu Z; UHN Bioinformatics and HPC Core, Toronto, ON, Canada.
  • Saunders ME; Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • Flavell RA; Department of Immunobiology, School of Medicine, Yale University, New Haven, CT, 06520, USA.
  • Mak TW; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, 06520, USA.
Cell Death Differ ; 30(2): 407-416, 2023 02.
Article em En | MEDLINE | ID: mdl-36528755
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalomielite Autoimune Experimental / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalomielite Autoimune Experimental / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá